Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Meyer

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Molecular Biology and Evolution|October 22, 2013
Decisive data sets in phylogenomics: lessons from studies on the phylogenetic relationships of primarily wingless insectsEmiliano Dell'Ampio, Karen Meusemann, Nikolaus U Szucsich, et al.
JCI Insight|September 1, 2022
Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survivalVinod Vijayakurup, Kyungah Maeng, Hye Seung Lee, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillanceJavier Perez-Saez, María-Eugenia Zaballa, Sabine Yerly, et al.
Journal of Clinical Medicine|April 30, 2021
Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence SettingsDiego O Andrey, Sabine Yerly, Benjamin Meyer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2021
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfectionPauline Vetter, Samuel Cordey, Manuel Schibler, et al.
Trials|November 25, 2025
Antiviral treatment in adult patients hospitalized for influenza: study protocol for a multi-center, randomized, placebo-controlled trial on the efficacy of baloxavir marboxil to reduce time to clinical improvement and the risk for severe complications (the INFLUENT trial)Krisztina Hosszu-Fellous, Antoine Poncet, Ana Rita Goncalves Cabecinhas, et al.
Frontiers in Immunology|May 19, 2022
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 - A Comprehensive AnalysisBenjamin Meyer, Paola Andrea Martinez-Murillo, Barbara Lemaitre, et al.
Nature Communications|July 5, 2022
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsMeriem Bekliz, Kenneth Adea, Pauline Vetter, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2016
p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1Yue Ma-Lauer, Javier Carbajo-Lozoya, Marco Y Hein, et al.
Porcine Health Management|June 1, 2023
Lesions and pathogens found in pigs that died during the nursery period in five Danish farmsKristiane Barington, Esben Østergaard Eriksen, Egle Kudirkiene, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Molecular Biology and Evolution|October 22, 2013
Decisive data sets in phylogenomics: lessons from studies on the phylogenetic relationships of primarily wingless insectsEmiliano Dell'Ampio, Karen Meusemann, Nikolaus U Szucsich, et al.
JCI Insight|September 1, 2022
Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survivalVinod Vijayakurup, Kyungah Maeng, Hye Seung Lee, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillanceJavier Perez-Saez, María-Eugenia Zaballa, Sabine Yerly, et al.
Journal of Clinical Medicine|April 30, 2021
Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence SettingsDiego O Andrey, Sabine Yerly, Benjamin Meyer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2021
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfectionPauline Vetter, Samuel Cordey, Manuel Schibler, et al.
Trials|November 25, 2025
Antiviral treatment in adult patients hospitalized for influenza: study protocol for a multi-center, randomized, placebo-controlled trial on the efficacy of baloxavir marboxil to reduce time to clinical improvement and the risk for severe complications (the INFLUENT trial)Krisztina Hosszu-Fellous, Antoine Poncet, Ana Rita Goncalves Cabecinhas, et al.
Frontiers in Immunology|May 19, 2022
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 - A Comprehensive AnalysisBenjamin Meyer, Paola Andrea Martinez-Murillo, Barbara Lemaitre, et al.
Nature Communications|July 5, 2022
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsMeriem Bekliz, Kenneth Adea, Pauline Vetter, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2016
p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1Yue Ma-Lauer, Javier Carbajo-Lozoya, Marco Y Hein, et al.
Porcine Health Management|June 1, 2023
Lesions and pathogens found in pigs that died during the nursery period in five Danish farmsKristiane Barington, Esben Østergaard Eriksen, Egle Kudirkiene, et al.
Pageof 12